Online citations, reference lists, and bibliographies.
← Back to Search

The Consortium To Establish A Registry For Alzheimer's Disease (CERAD)

S. S. Mirra, A. Heyman, D. McKeel, S. M. Sumi, B. Crain, L. Brownlee, F. Vogel, J. Hughes, G. V. Belle, L. Berg
Published 1991 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The Neuropathology Task Force of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed a practical and standardized neuropathology protocol for the postmortem assessment of dementia and control subjects. The protocol provides neuropathologic definitions of such terms as “definite Alzheimer's disease” (AD), “probable AD,” “possible AD,” and “normal brain” to indicate levels of diagnostic certainty, reduce subjective interpretation, and assure common language. To pretest the protocol, neuropathologists from 15 participating centers entered information on autopsy brains from 142 demented patients clinically diagnosed as probable AD and on eight nondemented patients. Eighty-four percent of the dementia cases fulfilled CERAD neuropathologic criteria for definite AD. As increasingly large numbers of prospectively studied dementia and control subjects are autopsied, the CERAD neuropathology protocol will help to refine diagnostic criteria, assess overlapping pathology, and lead to a better understanding of early subclinical changes of AD and normal aging.
This paper references
10.1212/WNL.37.5.754
Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients
S. Ditter (1987)
Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
C. Joachim (1989)
10.1002/ANA.410240110
Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases
C. Joachim (1988)
10.1001/ARCHNEUR.1989.00520420071025
Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?
J. Morris (1989)
10.1111/j.1365-2990.1989.tb01216.x
THE IMMUNOHISTOCHEMICAL DEMONSTRATION OF SUBSEQUENCES OF THE PRECURSOR OF THE AMYLOID A4 PROTEIN IN SENILE PLAQUES IN ALZHEIMER'S DISEASE
T. Ishii (1989)
A neuropathologic subset of Alzheimer's disease with concomitant Lewy body disease a n d spongiform change
H LAHANS
10.1097/00002093-198802040-00021
The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimerʼs disease: a clinicopathologic study of 57 cases
M. Tierney (1988)
Editorial: neuropathological diagnosis of Alzheimer disease
Z S Khachaturian (1985)
10.1212/WNL.35.11.1544
Clinical subtypes of dementia of the Alzheimer type
H. Chui (1985)
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.
D. Dickson (1988)
10.1001/ARCHNEUR.1986.00520070020010
Parkinson's disease in patients with Alzheimer's disease.
J. Leverenz (1986)
Quality assurance in the neuropathology assessment of Alzheimer's disease: a multicenter study of the Consortium to Establish a Registry for Alzheimer's disease
S S Mirra
Clinical-pathologic correlates of Parkinson's disease features in Alzheimer's disease
S M Ditter (1988)
10.1212/WNL.40.1.1
The Lewy body variant of Alzheimer's disease
L. Hansen (1990)
The pathological diagnosis of Alzheimer's disease: present neuropathological standards and future challenges
M J Ball (1987)
10.1212/WNL.39.9.1159
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease
J. C. Moms (1989)
The CERAD protocol for the neuropathologic assessment of Alzheimer’s disease and related disorders [Abstract
SS Mirra (1988)
10.1136/jnnp.51.8.1037
Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study.
T. Erkinjuntti (1988)
10.1056/nejm198803243181218
The site of the earliest lesions of Alzheimer's disease.
D. M. Mann (1988)
The CERAD protocol for the neuropathologic assessment of Alzheimer's disease and related disorders
S S Mirra (1988)
Hetrogeneity in dementia of the Alzheimer type: evidence of subgroups
R Mayeux
10.1111/j.1365-2990.1989.tb01232.x
AN ANALYSIS OF THE MORPHOLOGY OF SENILE PLAQUES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGES USING IMMUNOCYTOCHEMICAL AND LECTIN HISTOCHEMICAL TECHNIQUES
D. Mann (1989)
10.1002/ANA.410230509
Mild senile dementia of the alzheimer type: 2. Longitudinal assessment
L. Berg (1988)



This paper is referenced by
10.1212/01.wnl.0000341271.90478.8e
Vascular risk factors and dementia
A. Viswanathan (2009)
10.1007/s00115-010-3213-3
Diagnose ohne Therapie
H.-J. Gertz (2010)
10.1176/AJP.155.11.1536
Senile degeneration and cognitive impairment in chronic schizophrenia.
A. Dwork (1998)
10.1159/000051183
Neuropathology of White Matter Changes in Alzheimer’s Disease and Vascular Dementia
E. Englund (1998)
10.1212/WNL.49.6.1570
The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease
A. Churchyard (1997)
10.1080/13803390490509439
The Effect of the ApoE ϵ4 Allele on Recognition Memory for Olfactory and Visual Stimuli in Patients with Pathologically Confirmed Alzheimer’s Disease, Probable Alzheimer’s Disease, and Healthy Elderly Controls
P. Gilbert (2004)
10.1007/s00415-009-5243-y
Formation and development of Lewy pathology: a critical update
K. Jellinger (2009)
10.1016/B978-012369509-3.50018-4
16 – The Molecular Basis of Alzheimer's Disease
M. Ingelsson (2007)
TMEM 106 B gene polymorphism is associated with age at onset in granulin mutation carriers and plasma granulin protein levels
Carlos Cruchaga (2011)
A spatial pattern analysis of β-amyloid ( A β ) deposition in the temporal lobe in Alzheimer ' s disease
R. Armstrong (2010)
10.1186/1471-2377-1-3
Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype
K. Jellinger (2001)
10.1001/ARCHNEUR.59.7.1099
Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study.
J. Leverenz (2002)
10.1007/s00401-002-0529-5
Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria
G. Halliday (2002)
10.1159/000051282
The Swedish APP670/671 Alzheimer’s Disease Mutation: The First Evidence for Strikingly Increased Oxidative Injury in the Temporal Inferior Cortex
N. Bogdanovic (2001)
10.1016/S0197-4580(02)00009-X
Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology
R. Sweet (2002)
10.1046/j.1440-1827.2002.01402.x
Identification of an aging‐related spherical inclusion in the human brain
T. Kimura (2002)
10.1007/s00401-004-0967-3
Tuft-shaped astrocytes in Lewy body disease
N. Hishikawa (2004)
10.1006/BRBI.2000.0606
Age-Dependent Cytokine Responses: Trimethyltin Hippocampal Injury in Wild-Type, APOE Knockout, and APOE4 Mice
G. J. Harry (2000)
10.1111/j.1365-2990.2010.01067.x
Immunohistochemical evidence for macroautophagy in neurones and endothelial cells in Alzheimer's disease
J-F Ma (2010)
10.1016/S0197-4580(02)00227-0
Identifying severely atrophic cortical subregions in Alzheimer’s disease
G. Halliday (2003)
10.3389/fnagi.2015.00114
Can insulin signaling pathways be targeted to transport Aβ out of the brain?
M. Vandal (2015)
10.1016/j.gdata.2014.09.002
Genome-wide profiling of alternative splicing in Alzheimer's disease
M. Lai (2014)
10.3233/JAD-150707
Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.
J. Vallortigara (2016)
10.3233/JAD-141764
Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease.
Nur-Ezan Mohamed (2015)
10.1007/978-1-4614-0785-0_28
Chapter 28 Alpha-Synucleinopathy and Neuropsychological Symptoms in a Population-Based Cohort of the Elderly
J. Zaccai (2012)
Role of genomic copy number variation in Alzheimer's disease and mild cognitive impairment
S. Swaminathan (2012)
10.2967/jnumed.119.230458
Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers
I. Koychev (2020)
10.1212/WNL.0000000000010948
Longitudinal anatomic, functional, and molecular characterization of Pick disease phenotypes
J. Whitwell (2020)
10.1038/s41597-020-00650-8
Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease
L. Ping (2020)
10.1212/WNL.55.9.1284
MPO and APOEε4 polymorphisms interact to increase risk for AD in Finnish males
W. F. Reynolds (2000)
10.1016/S0022-510X(01)00638-4
Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies—an immunohistochemical study
K. Shiozaki (2001)
10.1212/01.WNL.0000046581.81650.D0
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D. Strozyk (2003)
See more
Semantic Scholar Logo Some data provided by SemanticScholar